Bharathi Vennapusa

Bharathi Vennapusa is Principal Pathologist I and Manager, CDx projects at Ventana Medical Systems, Inc., Tucson, AZ, USA.

Content by Bharathi Vennapusa:

Disease Area Cancer

In Good Company

05/26/2016 | Bharathi Vennapusa

What does it take to create a competitive companion diagnostic? Bharathi Vennapusa outlines her role in the development and approval of the ALK CDx – a fully-automated immunohistochemistry assay that identifies lung cancer patients who may be eligible for treatment with Pfizer’s Xalkori (crizotinib).